These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4019961)

  • 21. The Japanese perspective: effects of terfenadine in bronchial asthma: in vitro and in vivo research.
    Tasaka K; Tomioka H
    Ann Allergy; 1993 Sep; 71(3):312-6. PubMed ID: 7690527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Zaditen: a pharmacologic and therapeutic profile].
    Craps LP
    Allerg Immunol (Paris); 1988 Dec; 20(10):369-71. PubMed ID: 2463842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does regular treatment with ketotifen inhibit bronchoconstriction induced by isocapnic hyperventilation?
    Rafferty P; Tweeddale PM; Ferguson RJ; Biggs BA; Grant IW
    Br J Clin Pharmacol; 1987 Jul; 24(1):100-2. PubMed ID: 3304381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of the beta-adrenergic system: possible implications for the prophylactic action of ketotifen in asthma.
    Bretz U; Martin U; Mazzoni L; Engel G; Reinert H
    Triangle; 1982; 21(4):133-8. PubMed ID: 6304954
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells.
    Okayama Y; Church MK
    Int Arch Allergy Immunol; 1992; 97(3):216-25. PubMed ID: 1375203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ketotifen and bronchial hyperreactivity in asthmatic patients.
    Girard JP
    Clin Allergy; 1981 Sep; 11(5):449-52. PubMed ID: 7318164
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of immunological histamine release from guinea pig lungs and other organs by mepyramine, ketotifen, and picumast in vivo.
    Sekardi L; Friedberg KD
    Arzneimittelforschung; 1989 Oct; 39(10A):1331-5. PubMed ID: 2483312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitory effect of azelastine and ketotifen on histamine-induced bronchoconstriction in asthmatic patients.
    Magnussen H
    Chest; 1987 Jun; 91(6):855-8. PubMed ID: 2884081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of food on the bronchial response in adult asthmatic patients, and the protective role of ketotifen.
    Furlan J; Suskovic S; Rus A
    Allergol Immunopathol (Madr); 1987; 15(2):73-81. PubMed ID: 3618443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bronchial adrenergic receptors and asthma. Tachyphylaxis and its prevention].
    Pauwels R
    Allerg Immunol (Paris); 1988 Sep; 20(7):261-5. PubMed ID: 2846002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of ketotifen, nedocromil sodium and budesonide on non-specific bronchial hyperreactivity to histamine in patients with asthma].
    Siergiejko Z; Rutkowski R; Rogalewska A; Kazberuk M
    Pneumonol Alergol Pol; 1992; 60(11-12):37-42. PubMed ID: 1338947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketotifen prevents terbutaline-induced down-regulation of beta-adrenoceptors in guinea pig lung.
    Koshino T; Agrawal DK; Townley TA; Townley RG
    Biochem Biophys Res Commun; 1988 May; 152(3):1221-7. PubMed ID: 2897844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen bronchial challenge and efficacy after 4 weeks of treatment with ketotifen and disodium cromoglycate.
    Palmen FM
    Respiration; 1983; 44(2):103-8. PubMed ID: 6403976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term trial of ketotifen in bronchial asthma.
    Podleski WK; Zelenak TM; Schmidt JL
    Ann Allergy; 1984 Jun; 52(6):406-10. PubMed ID: 6428279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological rehabilitation of the asthmatic child.
    Debelić M
    Allergol Immunopathol (Madr); 1981; Suppl 9():99-102. PubMed ID: 6819777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction.
    Achterrath-Tuckermann U; Weischer CH; Szelenyi I
    Pharmacology; 1988; 36(4):265-71. PubMed ID: 3380879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanisms of antiinflammatory steroid action in allergic diseases.
    Schleimer RP
    Annu Rev Pharmacol Toxicol; 1985; 25():381-412. PubMed ID: 2988421
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmaco-prevention of bronchial asthma using membrane stabilizers and asthma mortality].
    Neffen HE
    Rev Alerg Mex (1987); 1990; 37(5):155-63. PubMed ID: 1965614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K; Akagi M; Izushi K; Mio M
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.